Insider sale details
Executive Vice President Israel Joseph sold 38,000 shares of Delek US Holdings common stock on March 4, 2026, receiving a total of $1.54 million for the disposal. The transaction carried a weighted average sale price of $40.65 per share, with individual trade prices reported between $40.10 and $40.93. After the sale, Joseph directly holds 55,623 shares of the company's common stock.
Market context and valuation
Delek US shares are trading at $42.29, a level close to the company's 52-week high of $45.74, following a pronounced 209% increase over the past year. Independent analysis from InvestingPro included in market commentary indicates that the stock appears overvalued at current levels. The company carries a market capitalization of $2.53 billion, while remaining unprofitable on a trailing-twelve-month basis with negative earnings per share of $0.34.
Quarterly results: contrast between profit and top line
In its fourth-quarter 2025 financials, Delek US reported an adjusted earnings per share of $2.31, which outpaced analysts' expectations of -$0.07 — a positive surprise quantified at 3,400%. Revenue for the same period totaled $2.43 billion, falling short of the anticipated $2.55 billion and representing a 4.71% negative surprise. The companyâs results therefore present a pronounced divergence: a sizable earnings beat alongside a revenue miss.
Market reaction
Investors responded favorably to the earnings release, and the company's stock rose following the report. These moves in the share price have occurred while the stock remains near its yearly high and amid the noted valuation concerns by third-party analysis.
Note on available analysis
Additional proprietary tips and deeper insights for investors in Delek US are available through InvestingPro, which advertises further guidance and specific valuation tools for interested subscribers.